CR7512A - Procedimiento para preparar derivados de 6-alquiliden-penem - Google Patents

Procedimiento para preparar derivados de 6-alquiliden-penem

Info

Publication number
CR7512A
CR7512A CR7512A CR7512A CR7512A CR 7512 A CR7512 A CR 7512A CR 7512 A CR7512 A CR 7512A CR 7512 A CR7512 A CR 7512A CR 7512 A CR7512 A CR 7512A
Authority
CR
Costa Rica
Prior art keywords
alquiliden
penem
procedure
prepare derivatives
derivatives
Prior art date
Application number
CR7512A
Other languages
English (en)
Inventor
Abe Takao
Matsunaga Hiroshi
Mihira Ado
Sato Chisato
Ushirogochi Hedeki
Sato Koichi
Takasaki Tsuyoshi
Mudumbai Venkatesan Aranapakam
Mansour Tarek
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR7512A publication Critical patent/CR7512A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/881—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrogen atom or an unsubstituted hydrocarbon radical, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se refiere a un nuevo procedimiento para la produccion de dreivados de 6-alquiliden-penem que pueden ser importantes como inhibidores de B-lactamasa de espectro amplio y agentes antibacterianos.
CR7512A 2002-05-01 2004-10-06 Procedimiento para preparar derivados de 6-alquiliden-penem CR7512A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37704802P 2002-05-01 2002-05-01

Publications (1)

Publication Number Publication Date
CR7512A true CR7512A (es) 2005-01-05

Family

ID=29401435

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7512A CR7512A (es) 2002-05-01 2004-10-06 Procedimiento para preparar derivados de 6-alquiliden-penem

Country Status (23)

Country Link
US (1) US20040053913A1 (es)
EP (1) EP1499620B1 (es)
JP (1) JP2005523937A (es)
KR (1) KR20050007369A (es)
CN (1) CN100516069C (es)
AR (1) AR039476A1 (es)
AT (1) ATE456569T1 (es)
AU (2) AU2003228773A1 (es)
BR (1) BR0309753A (es)
CA (1) CA2483533A1 (es)
CR (1) CR7512A (es)
DE (1) DE60331138D1 (es)
EC (1) ECSP045396A (es)
IL (1) IL164900A0 (es)
MX (1) MXPA04010661A (es)
NO (1) NO20044548L (es)
NZ (1) NZ536183A (es)
RU (1) RU2317297C2 (es)
SG (1) SG165159A1 (es)
TW (1) TW200403248A (es)
UA (1) UA78047C2 (es)
WO (1) WO2003093277A1 (es)
ZA (1) ZA200409687B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
US7316917B2 (en) 2003-05-16 2008-01-08 Wyeth Holdings Corporation Production of bicyclic-heteroaryl-2-carboxylic acids by selective enzymatic hydrolysis of a mixture of positional esters
TW200716104A (en) * 2005-06-01 2007-05-01 Wyeth Corp Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
CA2616468A1 (en) * 2005-07-27 2007-03-08 Wyeth Tricyclic 6-alkylidene-penem .beta.-lactamase inhibitors and .beta.-lactam antibiotic combination: a broad spectrum antibiotic
BRPI0613927A2 (pt) * 2005-07-27 2011-02-15 Wyeth Corp uso de cefepima ou um sal farmaceuticamente aceitável desta e um composto da fórmula i ou um sal farmaceuticamente aceitável ou éster deste hidrolisável in vivo; composição; embalagem; e produto
GT200600380A (es) * 2005-08-24 2007-03-29 Proceso para la preparacion de inhibidores de beta-lactamasa
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
US20100063023A1 (en) * 2008-09-10 2010-03-11 Wyeth Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors
CN102020658B (zh) * 2009-09-11 2012-05-23 中国中化股份有限公司 2-氯-6，8-二氢-5H-咪唑[2，1-c]-[1，4]噁嗪及其制备方法
CN102020615B (zh) * 2009-09-11 2012-08-29 中国中化股份有限公司 一种吗啉酮衍生物及其制备方法
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
CA2885692C (en) 2012-09-25 2018-05-22 Bayer Cropscience Ag Herbicidal and fungicidal 5-oxy-substituted 3-phenylisoxazoline-5-carboxamides and 5-oxy-substituted 3-phenylisoxazoline-5-thioamides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206067A (en) * 1978-10-02 1980-06-03 Chevron Research Company Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
ATE159021T1 (de) * 1986-01-17 1997-10-15 Beecham Group Plc Verfahren zur herstellung von penem derivaten und zwischenprodukte zu dieser herstellung
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
US4977256A (en) * 1987-12-07 1990-12-11 Lederle (Japan), Ltd. Method of eliminating protective groups
GB8729613D0 (en) * 1987-12-18 1988-02-03 Beecham Group Plc Novel compounds
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
CN1094353C (zh) * 1994-04-25 2002-11-20 史密斯克莱·比奇曼公司 含有β－内酰胺酶抑制性青霉烯与β－内酰胺抗生素复合的药物制剂及其在治疗细菌感染中的应用
ATE233089T1 (de) * 1998-10-15 2003-03-15 Sarawak Medichem Pharmaceuticals Inc Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos

Also Published As

Publication number Publication date
JP2005523937A (ja) 2005-08-11
EP1499620A1 (en) 2005-01-26
RU2317297C2 (ru) 2008-02-20
BR0309753A (pt) 2005-03-08
DE60331138D1 (de) 2010-03-18
WO2003093277A1 (en) 2003-11-13
ATE456569T1 (de) 2010-02-15
EP1499620B1 (en) 2010-01-27
CA2483533A1 (en) 2003-11-13
SG165159A1 (en) 2010-10-28
MXPA04010661A (es) 2005-01-25
ECSP045396A (es) 2005-01-03
US20040053913A1 (en) 2004-03-18
NO20044548L (no) 2004-11-26
ZA200409687B (en) 2009-02-25
TW200403248A (en) 2004-03-01
IL164900A0 (en) 2005-12-18
AU2010200930A1 (en) 2010-04-01
AU2003228773A1 (en) 2003-11-17
CN100516069C (zh) 2009-07-22
NZ536183A (en) 2006-07-28
CN1649881A (zh) 2005-08-03
AR039476A1 (es) 2005-02-23
KR20050007369A (ko) 2005-01-17
UA78047C2 (en) 2007-02-15
RU2004135088A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
CR7512A (es) Procedimiento para preparar derivados de 6-alquiliden-penem
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
TN2010000203A1 (en) Beta-lactamase inhibitors
GEP20125537B (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
CL2007001435A1 (es) Compuestos derivados de fenilalanina; proceso de prepatacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como inhibidores de integrina para el tratamiento del cancer.
HN2009001165A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
UY29246A1 (es) Nuevos compuestos
MX336381B (es) Boronatos como inhibidores de arginasa.
TNSN08140A1 (es)
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
CL2008003265A1 (es) Compuestos derivados de heterociclos nitrogenados, supresores de la produccion de colageno; composicion farmaceutica que comprende dichos compuestos; y su uso para prevenir y/o tratar la fibrosis y/o los tumores.
GEP20094679B (en) Dipeptidyl peptidase inhibitors
NO20090313L (no) Derivater og analoger av N-etylkinoloner og N-etylazakinoloner
CL2008000873A1 (es) Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis.
MEP15908A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
CL2012003602A1 (es) Compuestos heterociclicos nitrogenados fusionados, moduladores de fosfodiesterasas; un medicamento; un método para prevenir o tratar la esquizofrenia; y su uso para la produccion de un agente para prevenir o tratar la esquizofrenia.
RS54863B1 (sr) Upotreba sredstva za suzbijanje vlažne truleži i postupak suzbijanja iste
CL2008002185A1 (es) Compuestos derivados de pirimidina, inhibidores de fosfatidilinositol-3-cinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de enfermedades resapiratorias, alergias, inflamacion, cancer, entre otras enfermedades.
GEP20125458B (en) Matrix metalloproteinase inhibitors
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
AU2001230395A1 (en) Use of cox-2 inhibitors as gastroprokinetics
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents